Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Pharmacia terminates collaboration with Epimmune for cancer vaccine development

Nov. 17, 2000

Lorus seeks FDA approval to move GTI-2501 to clinical testing

Nov. 17, 2000

MGI Pharma to purchase Hexalen from MedImmune

Nov. 17, 2000

BASF presents small molecules with tyrosine kinase-inhibitory activity

Nov. 16, 2000

Acronycine analogue S-23906 confirmed as a potential development candidate for solid tumors

Nov. 16, 2000

Promising phase III results with Gliadel as first-line treatment of malignant glioma

Nov. 16, 2000

Verteporfin shows promise in clinical trials for the treatment of skin cancer

Nov. 16, 2000

Licensing opportunity from NIH: vaccinia virus vector for cancer therapy

Nov. 16, 2000

Pfizer prepares series of 2-pyridinylguanidine urokinase inhibitors

Nov. 15, 2000

Two series of styryl sulfone antitumor agents reported recently by U.S. university researchers

Nov. 15, 2000

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...